More recently, signalling through the ErbB3 pathway has been reported to correlate with expression of its natural ligand, neuregulin-1 (NRG1) in both ovarian cancer cell lines and in primary human ovarian cancer cells (Sheng et al, 2010). Here, ERBB3 is linked to ovarian cancer.